$WORX

SCWorx Corp. (WORX): Entry into a Material Definitive Agreement

SCWorx Corp. (WORX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement On September 16, 2026, SCWorx Corp. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with ten accredited investors (the “Purchasers”), pursuant to which the

Original reporting
Published Sep 22, 2026, 8:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$WORX
Neutral
medium confidence
Mentioned
$WORX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WORXNeutralLow
01

Why it matters

The filing provides the first public disclosure of the raise, confirming cash inflow and dilution details. No prior public information existed.

02

Market read

A micro‑cap equity raise of under $1M; primarily relevant to current shareholders and potential investors monitoring dilution risk.

03

What to watch

The attached warrants and anti‑dilution provisions could become valuable if the stock price appreciates sharply.

Relevance 6/10Novelty 6/10Timing: post‑filing today

Background

SCWorx Corp filed a Form 8‑K reporting entry into a securities purchase agreement and unregistered sale of equity securities, detailing the private placement terms and related placement agency agreement.

Company-level read

Ticker impact

$WORXNeutralMedium confidence
Context

SCWorx Corp disclosed a private placement of 350,000 shares and warrants raising $938,000, a material definitive agreement filing on Form 8‑K.

Expected impact

Minor downward pressure as new shares dilute equity; no immediate catalyst for large moves.

Evidence & confidence

The amount is small for a public company and the terms are standard; investors may view the cash as helpful but dilution offsets benefit.

Market effects

Limited; private‑placement activity is typical for micro‑caps and does not signal broader sector trends.

None; the filing pertains only to SCWorx Corp.

Minimal; the raise is under $1M and unlikely to affect market‑wide sentiment.

Counterpoint

If the capital is needed for critical R&D or debt repayment, the modest raise could be a catalyst for upside once milestones are met.

Key entities

  • SCWorx Corp.

    Issuer of the private placement.

  • Dawson James Securities, Inc.

    Exclusive placement agent receiving fee shares and cash compensation.

Related articles

$WORXHigh

SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy

SCWorx Corp. (Nasdaq: WORX) resumed trading on Nasdaq after regaining compliance with listing requirements. The company reported improved operating performance, with Q2 2026 revenue of $706,000 and gross profit up 83% YoY. Net loss declined significantly, and cash usage decreased. SCWorx aims to grow its healthcare customer base and leverage AI for data management.

$WORXMed

SCWorx Corp. (WORX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SCWorx Corp. (WORX) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Summary Company Completed Offering to Cure Nasdaq Publicly Held Shares Deficiency and Submitted Request for Reconsideration; Common Stock Continues to Be Quoted on OTCQB

Med

SCWorx Corp.: SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company's Continued Listing on the Nasdaq Capital Market

SCWorx Corp. said Nasdaq’s Hearings Panel issued a partial compliance letter confirming completion of the first benchmark in its approved plan to regain compliance for continued listing. The remaining requirement is to meet the Nasdaq minimum bid price of at least $1.00 for 20 consecutive trading days, under Listing Rule 5815(c)(4).